ArticleBMC pediatrics2025
Neonatal hypophosphatasia: a case report of a rare genetic disorder.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeonatal Hypophosphatasia is a rare condition attributed to loss of function mutations in the ALPL gene, resulting in diminished activity of Tissue Non-Specific Alkaline Phosphatase (TNSALP). While it can manifest at various life stages, neonatal onset is particularly ominous, often leading to fatal outcomes. The syndrome's diverse clinical manifestations pose a diagnostic challenge, necessitating a meticulous approach to rule out other differentials. CASE PRESENTATION: In our case, the observation of neonate's anomalous posture prompted a comprehensive diagnostic evaluation, including imaging studies. The results of the babygram raised concerns about a potential metabolic bone disorder, leading to a thorough investigation of alkaline phosphate levels. Persistent low levels further raised suspicion for Hypophosphatasia. We provided supportive treatment to the patient which included ventilator support, anti-epileptics for seizures, initially fluids later feed optimization with low calcium formula, vitamin D restriction, and gentle handling along with antibiotics for existing infection. Genetic testing was subsequently performed, confirming the presence of a loss of function mutation in the ALPL gene.
conclusionOur case highlights the significance of astute clinical observation, imaging studies, and biochemical assessments in unveiling this rare disorder. Early identification through a systematic approach allows for timely initiation of treatment, potentially ameliorating outcomes. By elucidating the disease's symptoms, this case contributes to a better understanding of its natural history, emphasizing the imperative for early intervention to enhance patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.